Trioday Tablet

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them. Common side effects of Trioday are as follows:

• ​Headache
  
• Dizziness
  
• Drowsiness
  
• Insomnia / Sleeplessness
  
• Abnormal dreams
  
• Impaired concentration
  
• Nausea
  
• Vomiting
  
• Diarrhea
  
• Indigestion / Dyspepsia
  
• Abdominal pain
  
• Bloating / Flatulence
  
• Rash / Skin reactions
  
• Hair loss
  
• Weakness / Fatigue
  
• Fever
  
• Cough
  
• Back pain
  
• Joint pain
  
• Muscle pain
  
• Bone disorders
  
• Anxiety
  
• Depression
  
• Severe mood disturbances
  
• Confusion / Forgetfulness
  
• Seizures / Tremor
  
• Peripheral neuropathy (tingling/numbness in hands and feet)
  
• Severe allergic reactions (wheezing, swelling, swelling, lightheadedness)
  
• Autoimmune disorders
  
• Anemia
  
• Decreased white blood cell count (neutropenia)
  
• Hypercholesterolemia (high cholesterol)
  
• Increased triglycerides
  
• Elevated creatinine kinase
  
• Elevated serum amylase
  
• Increased transaminases (liver enzymes)
  
• Liver toxicity
  
• Kidney damage (including blood in urine)
  
• Lipodystrophy (skin thickening or pits at injection site)
  
• Pneumonia

• Trioday Tablet contains three drugs that retard or stop the progression of HIV.
• The best way to take it is on an empty stomach, preferably in the evening. 
• Do not miss doses, as this may render your treatment ineffective.
• Do not crush, chew, or split the tablet.
• Trioday can make you dizzy or sleepy, so be careful when you are driving or doing anything that needs you to be alert until you know how you react to it.
• It may cause malformations, so avoid pregnancy during and for 12 weeks after taking it.
• Trioday can cause bone weakening; exercise and take calcium and vitamin D supplements.
• The doctor might check your kidney and liver; if you have stomach pain, no appetite, dark urine or yellow eyes or skin, tell your doctor.
• Don't stop Trioday without consulting your doctor.
  

• Arribas, J. R., et al. (2008). Tenofovir disoproxil fumarate, emtricitabine, and efavirenz versus fixed-dose zidovudine/lamivudine and efavirenz in antiretroviral-naive patients: 96-week analysis. Journal of Acquired Immune Deficiency Syndromes, 47(1), 74–78 - https://pubmed.ncbi.nlm.nih.gov/17971715/
• Cassetti, I., et al. (2006). The safety and efficacy of tenofovir DF (TDF) + lamivudine (3TC) + efavirenz (EFV) through 5 years in antiretroviral-naïve patients. 8th International Congress on Drug Therapy in HIV Infection, Glasgow, UK - https://pubmed.ncbi.nlm.nih.gov/17621463/
  
• DeJesus, E., et al. (2009). Tenofovir disoproxil fumarate, emtricitabine, and efavirenz versus fixed-dose zidovudine/lamivudine and efavirenz in antiretroviral naïve patients: 96-week analysis. Journal of Acquired Immune Deficiency Syndromes, 47(1), 74–78 - https://pubmed.ncbi.nlm.nih.gov/17057609/
  
• Efficacy and Safety of Tenofovir and Lamivudine in Combination with Efavirenz in Patients Co-infected with Human Immunodeficiency Virus and Hepatitis B Virus in China, (n.d.). PubMed. Retrieved from the PubMed database - https://pubmed.ncbi.nlm.nih.gov/26831232/
  
• Gallant, J., et al. (2005). Tenofovir DF (TDF) in combination with lamivudine (3TC) and efavirenz (EFV) in antiretroviral naive HIV infected patients: a 4-year follow-up.
• Pujari, S., Dravid, A., Gupte, N., Joshi, K., & Bele, V. (2008). Effectiveness and safety of a generic fixed-dose combination of tenofovir/emtricitabine/efavirenz in HIV 1 infected patients in Western India. Medscape Journal of Medicine, 10(8), 196.​